跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Telmisaph-A45 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Telmisaph-A45
Approved
STANDARD
Telmisaph-A45
Sai Parenterals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4c8844d864d165ab
Company
Sai Parenterals Ltd.
Type
Standard
Approval Details
Approval Id
4c8844d864d165ab
Drug Approval Philippines Name
Telmisaph-A45
Product Name
Telmisaph-A45
Registration Number
DRP-11813
Brand Name
Telmisaph-A45
Generic Name
Telmisartan + Amlodipine (as besilate)
Dosage Form
Tablet
Dosage Strength
40 mg/5 mg
Manufacturer
Sai Parenterals Ltd.
Importer
Nelpa Lifesciences, Inc.,
Distributor
Nelpa Lifesciences, Inc.,
Issuance Date
25 March 2025
Expiry Date
25 March 2030
Pharmacologic Category
Angiotensin II Receptor Blockers (ARBS)/ Calcium
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4c8844d864d165ab
Type
Standard
Back to Philippines FDA Approvals